title: Does parenteral oestrogen therapy flare up disease activity in patients with systemic lupus erythematosus complicated by haemorrhagic cystitis?
authors.forename: L Y
authors.initials: LY
authors.lastname: Yang
authors.forename: W J
authors.initials: WJ
authors.lastname: Huang
authors.forename: W P
authors.initials: WP
authors.lastname: Chen
authors.forename: L W
authors.initials: LW
authors.lastname: Fu
authors.forename: C Y
authors.initials: CY
authors.lastname: Lin
mesh_terms: D000293:Adolescent; D003520:Cyclophosphamide / Q000009:adverse effects; D003556:Cystitis / Q000150:complications / Q000188:drug therapy*; D004967:Estrogens / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D006470:Hemorrhage / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy*
chemical_list: D004967:Estrogens; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide